肺硬化性血管瘤的组织发生学研究

来源 :中德临床肿瘤学杂志(英文版) | 被引量 : 0次 | 上传用户:zhuchunjiangqq
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To investigate the histogenesis and differential diagnosis of pulmonary sclerosing hemangioma (PSH).Methods: Thyroid transcription factor-1 (TTF-1), surfactant proteins A, B (SP-A, SP-B), epithelial membrane antigen (EMA),vimentin, pancytokeratin, cytokeratin7 (CK7), CK5/6, calretinin, S-100, neurospecific enolase (NSE), synaptophysin (Syn),chromogranin A (CgA), CD34, factor-Ⅷ-related antigen (F-Ⅷ) and smooth muscle actin (SMA) in 55 patients with PSH were examined with immunohistochemistry, while samples from 19 patients were also observed by electron microscope. Followup information were reviewed. Results: Pathologically, PSH mainly consisted of both surface lining cuboidal cells and pale polygonal cells. Immunohistochemitry revealed that coexpression of TTF-1, EMA and vimentin in both cuboidal and polygonal cells was 94.5 % (52/55), 90.5% (50/55) and 58.2% (32/55), respectively. In cuboidal cells, the expression of SP-A and SP-B was 92.7% (51/55) and 81.8 % (45/55), respectively. Whereas pancytokeratin and CK7 immunostained the cuboidal cells in all cases. The polygonal cells were difussed immunostained with Syn in 13 PSHs (24%) and NSE in 8 PSHs (15%), while immunoreactions with S-100 and CgA were separated detected in 7 PSHs (13%). There was no significant difference of TTF-1and EMA expression between these two cells (X2 value was 1.371 and 3.352, respectively. P > 0.05). in contrast, there was a significant difference of vimentin between them (X2 value was 17.720, P < 0.001 ). Electron microcopy observation showed that ultrastructure may not differ from each other sometime. The follow-up was obtained for 49 cases ranged from 3 months to 14years. 48 of them had no recurrence or metastasis except one case had recurrence. Conclusion: PSH may origin from the primitive respiratory epithelial. Polygonal and cuboidal cells are all parenchymal neoplasm cells. The concomitant examination of TTF-1, SPA, SP-B, EMA, vimentin and pancytokeratin may favor the diagnosis and differential diagnosis of PSH.
其他文献
通过对武汉近代建筑保护实践的研究,讨论武汉近代建筑保护中的若干重要问题,提出相关的建议。
目的:研究以bcl-2基因为靶标有效siRNA-2(small interference RNA)能否提高急性原代白血病细胞对阿糖胞苷(Ara-C)敏感性.方法:将siRNA转入原代白血病细胞并与Ara-C联合培养,
A 45-year-old man with bronchioloalveolar carcinoma was treated with gefitinib. The most severe side effect was hemorrhagic cystitis but he had a dramatic respo
目的 联合检测Ⅰ期非小细胞肺癌(NSCLC)的细胞增殖,凋亡和血管生成,探讨Ⅰ期非小细胞肺癌预后分层.方法 应用免疫组织化学方法检测118例Ⅰ期非小细胞肺癌,30例肺良性组织和30
目的:观察碱性成纤维生长因子(bFGF)处理的缺血再灌注不同时程的猫脑组织中微管相关蛋白(MAP-2)和神经丝蛋白(NTP)的表达,探讨bFGF治疗缺血性脑损伤的可能作用机制。方法:健
目的:初步分析人核受体hLRH-1不同变异体在多种肿瘤组织和细胞系中的表达。方法:常规RT-PCR法分析hLRH-1v1和hLRH-1在肝癌等多种肿瘤组织和HepG2等肿瘤细胞系中的表达情况,实
目的探讨发病第7天肌钙蛋白I(cTnI)水平在急性心肌梗死(AMI)患者预测预后中的价值。方法采用全自动化学发光免疫分析系统,应用化学发光法测定发病第7天cTnI水平。观察117例AM
慢性重型肝炎患者,因其病程迁延,病机复杂,多脏腑功能失调,有虚实夹杂的多种证候群并存,故在治疗上颇为棘手.它既不同于“急黄”治疗,也不同于通常所见的肝炎黄疸的治疗.
目的:探讨造血干细胞移植(HSCT)治疗恶性血液病过程中心血管并发症的发生.方法:对1990年8月至2007年8月我院244例造血干细胞移植患者并发心血管疾病的情况进行回顾性分析.结
近年来,对心房颤动治疗方法的探讨已成为医学界研究的焦点问题并取得了很大进展,同时胺碘酮在心房颤动治疗中的地位也有所改变。目前胺碘酮在心房颤动中的地位如何,怎样合理